The Director of the Cell and Gene Therapy Program holds enterprise-wide accountability for the strategic direction, operational performance, and growth of the Cell and Gene Therapy portfolio. This role provides visionary leadership in planning, organizing, and managing multidisciplinary workgroups to deliver innovative, high-quality care. At the enterprise level, the Director drives the development and execution of care delivery models, operational optimization strategies, and business plans that enhance patient experience, ensure financial sustainability, and advance institutional objectives.
This position encompasses direct oversight of all Cell and Gene Therapy services across the health system and requires strong collaboration with executive and clinical leaders to achieve system-wide optimization across all settings of care. The role combines strategic foresight with operational rigor to drive transformative initiatives at scale.
Organizational Relationships
- Program Oversight: Provides direct executive leadership for the Cell and Gene Therapy Program, ensuring strategic alignment and operational excellence across all settings.
- Reporting Relationship: Reports directly to the Associate Chief Nursing Officer (ACNO), serving as a key member of the senior leadership team.
- Collaborative Leadership: Partners with the ACNO, ACCO, ACCC, Associate Directors, Senior Nursing Directors to drive strategic priorities, operationalize initiatives, and achieve organizational objectives.
- Strategic Alignment: Partners with department/program leadership to align goals with Michigan Medicine enterprise strategy, developing and executing plans that advance institutional priorities and clinical innovation.